1. Introduction
Vaccination is a cost-effective public health measure that can prevent the spread of diseases and reduce the morbidity burden [
1]. High vaccine uptake leads to a decline in the prevalence of vaccine-preventable diseases (VPDs) [
2]. Vaccines are safe and effective and, although like medication they can cause adverse effects, these adverse effects are outweighed by individual and collective benefits [
1,
3].
The Strategic Advisory Group of Experts (SAGE) Working Group on Vaccine Hesitancy concluded that vaccination hesitancy refers to delay or refusal of vaccination despite the availability of vaccination services. Vaccine hesitancy is complex and context specific, varying across time, place and vaccines. It is influenced by factors such as complacency, convenience and confidence [
4]. Declines in vaccination present threats to herd immunity [
5].
According to the World Health Organization (WHO), 1.5 million child deaths from VPDs occur every year worldwide This is partly due to problems of access to vaccines for socio-economic reasons, and partly to vaccination hesitancy generated by the rise of anti-vaccine movements [
6,
7]. Vaccination hesitancy is considered a priority line of action for the WHO and a challenge for those countries working to close the immunisation gap [
8,
9].
The SAGE Group noted that the Vaccine Hesitancy Determinants Matrix displays the factors influencing the behavioural decision to accept, delay or reject some or all vaccines under three categories: contextual, individual and group, and vaccine/vaccination-specific influences [
4]. A publication analysing the psychological factors that might motivate people in 25 countries to refuse vaccination showed that the best predictors of refusal were the following: high levels of conspiracy beliefs, low tolerance of perceived infringement of personal freedom, aversion to needles or blood, and religious beliefs [
10]. Another review highlighted the complexity of factors related to acceptance or refusal of vaccines including demographic factors (ethnicity, age, sex, pregnancy, education, and employment), accessibility and cost of vaccines, personal responsibility and risk perceptions, trust in healthcare authorities and vaccines, safety and efficacy of new vaccines, and lack of information or misinformation [
11].
In Spain, vaccination coverage is high, but varies depending on the vaccine. Data published by the Spanish Ministry of Health in 2022 showed a slight increase from the previous year in primary vaccination coverage (Polio, DTaP, Hib, Hepatitis B, Meningococcus C, Pneumococcus), as evidenced by the percentage of the population receiving the second dose of the hexavalent vaccine (DTaP, Hib, Hepatitis B) increasing from 96.8% in 2021 to 97.6% in 2022. However, coverage of two doses of the Measles, Mumps, and Rubella (MMR) vaccine in 2022 was 92.6% which did not meet the target coverage of ≥95% needed to keep measles’ elimination status, even if coverage was achieved considering only one dose. After the positive effect of the COVID-19 pandemic on influenza vaccine coverage, there was a decreasing trend in in influenza vaccine coverage all population groups, while still remaining higher than pre-pandemic levels [
12].
Vaccine hesitancy had been previously studied in Spain in specific groups such as HCPs and epidemiologists, so we consider it interesting to study it in the general population. [
13,
14]. Our study aimed to characterise the profile of the Spanish population with vaccination refusal specifically and hesitancy in general, to help HCPs conduct targeted vaccination campaigns to improve vaccination coverage. With this objective, we used an online questionnaire to describe the socio-demographic and sociocultural characteristics, beliefs and opinions of those refusing to have vaccine and those with hesitancy about vaccination, and their vaccination behaviours by vaccine type and sex.
2. Materials and Methods
2.1. Study Design
We performed an observational study in the Spanish population aged 18 years or older who had access to the online survey in 2021 and the faculty to decide on their own or others’ vaccination.
We obtained the information through an online, self-administered questionnaire designed by the project research team. A pilot test was performed before the definitive questionnaire was obtained. Both were registered on a Research Electronic Data Capture (REDCap) web platform stored on a centralized server where the data remain securely in the custody of the Institut Català de la Salut [Catalan Institute of Health]. Anonymous information was exported to the statistical packages used for later analysis. The REDCap platform generated a link (15) for participation in the survey that was disseminated through scientific societies, social networks, research institutes, paediatricians, and nurses in primary care.
2.2. Variables
The main variables of the questionnaire were: sociodemographic factors (sex, age, having children under 15 years old, level of education); sociocultural factors (religious beliefs, culture, family); vaccine information variables (whether they have refused any vaccines and, in that case, the type of vaccine refused; who the refused vaccine was for; hesitancy due to vaccine components, associated diseases or to the payment of vaccines; whether they know that personal vaccination protects other people whether they would be in favour of free and compulsory vaccination; opinion about vaccines), variables of trust in the health system (sources of information about vaccines, whether HCPs can understand anti-vaccine arguments, whether HCPs have enough information to satisfy anti-vaccine people, whether when in doubt about vaccines they will consult the HCP); habits (type of diet, consumption of cow’s milk, opinion on breastfeeding or artificial breastfeeding, opinion on alternative treatments or complementary treatments).
2.3. Statistical Analysis
The data were gathered in an anonymized database using the REDCap platform. We conducted a descriptive analysis of the findings, categorizing qualitative or ordinal data using absolute and relative frequencies. We evaluated the relative frequency of the categorical variables using the Chi square test or Fisher’s exact test and identified the variables that were both statistically significant and clinically relevant. In selected subgroups of interest, we identified the factors independently associated with these results. The relationship between the variables is quantified using Odds Ratios (ORs), with 95% confidence interval (CI) estimates, as a measure of association for risk. We used logistic regression to identify which factors are independently linked to vaccination refusal or to hesitancy due to vaccine components or diseases that have been associated to being vaccinated. We employed a stepwise conditional variable recall model that retains variables at an adjusted p-value of <0.05 and excludes variables with a value >0.10. This included factors that were statistically significant in our initial comparisons of two variables at a time. We report the likelihood of these factors as ORs and their statistical significance (as adjusted p-values), using a cut-off of p<0.05 to define statistical significance. All analysis was conducted using SPSS software version 26.0.
2.4. Ethical Considerations
This study was approved by the ethics and clinical Research Committee of the Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), with code 20/221-P. The study was conducted following the principles of the Declaration of Helsinki. The variables collected were treated anonymously to guarantee the confidentiality of the data, as established in Regulation (EU) 2016/679 of the European Parliament and the Council of April 27 on Data Protection (RGPD) and the Spanish Organic Law 3/2018, of the 5th December 2018, regarding the protection of personal data and guarantees of digital rights. The database is kept by the principal investigator and the research team in an Excel format, protected by password access. An anonymized database was used for the analysis. Before conducting the survey, online informed consent was completed, accepted, and signed.
3. Results
3.1. Description of the Study Population and Percentages of Vaccine Refusal and Hesitancy (Table 1)
There was a total of 1312 respondents to the survey: 74.5% were females and 25.5% males; 14.0% were under 31 years old, 73.7% between 31-59, and 12.4% over 59. Out of all the respondents, 1294 responded to the question of whether they had ever refused a vaccine, with 16.8% (218/1294) of these claiming to have indeed refused vaccines.
Of the 218 respondents who had refused vaccines, the most commonly refused vaccine was for influenza (61.9%) followed by tetanus (18.3%) and papilloma (HPV) (16.1%). Other vaccines refused included the following: chicken pox (14.2%); hepatitis B (12.8%); MMR (10.1%); hepatitis A (8.3%); and diphtheria, pneumococcus, and polio (each 6.9%). A small proportion declined the vaccine for pertussis (6.4%), meningococcus C (5.5%), and haemophilus influenzae type B (3.7%). A percentage of 17.0% of respondents who had refused vaccines could not remember which vaccine they refused and 5.5% did not specify. Among the vaccines not funded by Spanish Health System in 2019, refusal rates were 11.0% for rotavirus, 8.3% for Meningococcus B, and 6.9% for Meningococcus ACWY. Of those who had refused vaccines, the majority (66%) had refused just one vaccine, while 34% had refused two or more. Most (73.4%) had refused vaccines for themselves, while some (34.4%) for their children, and just a few (3.7%) for their parents or others.
Hesitancy due to vaccine components was cited by 28.1% of respondents, associations with disease that have been linked to vaccines by 30.9%, and the fact that some vaccines must be paid for by 29.0%.
When looking at the overall support respondents showed for vaccines, a significant majority (76.1%) expressed strong support for vaccines, 16.7% showed slight agreement, and only a small fraction expressed indifference, or a slight or strong disagreement to vaccines (2.4%, 3.4%, and 1.3% respectively).
Table 1.
Description of the study population.
Table 1.
Description of the study population.
Sociodemographic Data |
Total N=1312 |
* Responders to Q25 n=1294 |
Refusers n=218 |
Gender (binary): |
|
|
|
Men |
326 (25.5%) |
325 (25.5%) |
53 (24.5%) |
Women |
954 (74.5%) |
952 (74.5%) |
163 (75.5%) |
Age (recodified): |
|
|
|
30 years old or less |
180 (14.0%) |
180 (14.0%) |
25 (11.6%) |
31-59 years old |
948 (73.7%) |
947 (73.8%) |
151 (69.9%) |
60 years old or more |
159 (12.4%) |
157 (12.2%) |
40 (18.5%) |
University studies: |
|
|
|
No |
374 (29.0%) |
372 (28.9%) |
58 (26.7%) |
Yes |
915 (71.0%) |
914 (71.1%) |
159 (73.3%) |
Do you have sons or daughters under 15 years old? |
|
|
|
Yes |
604 (46.9%) |
603 (46.9%) |
106 (48.6%) |
No |
685 (53.1%) |
683 (53.1%) |
112 (51.4%) |
Your religious beliefs are: |
|
|
|
In favour of vaccination |
467 (35.6%) |
466 (36.0%) |
51 (23.4%) |
Against vaccination |
6 (0.5%) |
6 (0.5%) |
2 (0.9%) |
I have no opinion |
237 (18.1%) |
220 (17.0%) |
61 (28.0%) |
I am not a believer |
494 (37.7%) |
494 (38.2%) |
92 (42.2%) |
I do not know |
108 (8.2%) |
108 (8.3%) |
12 (5.5%) |
Your culture is: |
|
|
|
In favour of vaccination |
1111 (84.7%) |
1109 (85.7%) |
161 (73.9%) |
Against vaccination |
14 (1.07%) |
14 (1.08%) |
9 (4.13%) |
I have no opinion |
128 (9.76%) |
112 (8.66%) |
36 (16.5%) |
I do not know |
59 (4.50%) |
59 (4.56%) |
12 (5.50%) |
Your family is: |
|
|
|
In favour of vaccination |
1165 (88.8%) |
1163 (89.9%) |
164 (75.2%) |
Against vaccination |
32 (2.44%) |
32 (2.47%) |
14 (6.42%) |
Has no opinion |
90 (6.86%) |
74 (5.72%) |
31 (14.2%) |
I do not know |
25 (1.91%) |
25 (1.93%) |
9 (4.13%) |
Opinion about vaccinations |
Total N=1312
|
*Responders to Q25 n=1294
|
Refusers n=218
|
Have you ever refused a vaccine? |
218 (16.8%) |
1294 |
218 (16.8%) |
1294 |
218 (100%) |
218 |
Which vaccine have you refused? (choice=Diptheria) |
15 (1.14%) |
1312 |
15 (1.16%) |
1294 |
15 (6.88%) |
218 |
Which vaccine have you refused? (choice=Influenza) |
135 (10.3%) |
1312 |
135 (10.4%) |
1294 |
135 (61.9%) |
218 |
Which vaccine have you refused? (choice=Haemophilus influenzae type B) |
8 (0.61%) |
1312 |
8 (0.62%) |
1294 |
8 (3.67%) |
218 |
Which vaccine have you refused? (choice=Hepatitis A) |
18 (1.37%) |
1312 |
18 (1.39%) |
1294 |
18 (8.26%) |
218 |
Which vaccine have you refused? (choice=Hepatitis B) |
28 (2.13%) |
1312 |
28 (2.16%) |
1294 |
28 (12.8%) |
218 |
Which vaccine have you refused? (choice=Meningococcus ACWY(Nimenrix®, Menveo®)) |
15 (1.14%) |
1312 |
15 (1.16%) |
1294 |
15 (6.88%) |
218 |
Which vaccine have you refused? (choice=Meningococcus B (Bexero®, Trumemba®)) |
18 (1.37%) |
1312 |
18 (1.39%) |
1294 |
18 (8.26%) |
218 |
Which vaccine have you refused? (choice=Meningococcus C) |
12 (0.91%) |
1312 |
12 (0.93%) |
1294 |
12 (5.50%) |
218 |
Which vaccine have you refused? (choice=Pneumococcus) |
15 (1.14%) |
1312 |
15 (1.16%) |
1294 |
15 (6.88%) |
218 |
Which vaccine have you refused? (choice=Polio) |
15 (1.14%) |
1312 |
15 (1.16%) |
1294 |
15 (6.88%) |
218 |
Which vaccine have you refused? (choice=Rotavirus (Rotarix ®, Rotateq®)) |
24 (1.83%) |
1312 |
24 (1.85%) |
1294 |
24 (11.0%) |
218 |
Which vaccine have you refused? (choice=Tetanus) |
40 (3.05%) |
1312 |
40 (3.09%) |
1294 |
40 (18.3%) |
218 |
Which vaccine have you refused? (choice=Whooping cough) |
14 (1.07%) |
1312 |
14 (1.08%) |
1294 |
14 (6.42%) |
218 |
Which vaccine have you refused? (choice=Triple vírica (MMR)) |
22 (1.68%) |
1312 |
22 (1.70%) |
1294 |
22 (10.1%) |
218 |
Which vaccine have you refused? (choice=Papiloma virus HPV) |
35 (2.67%) |
1312 |
35 (2.70%) |
1294 |
35 (16.1%) |
218 |
Which vaccine have you refused? (choice=Varicella) |
31 (2.36%) |
1312 |
31 (2.40%) |
1294 |
31 (14.2%) |
218 |
Which vaccine have you refused? (choice=I do not remember) |
37 (2.82%) |
1312 |
37 (2.86%) |
1294 |
37 (17.0%) |
218 |
Number of vaccines refused |
0.37 (1.54) |
1312 |
0.37 (1.55) |
1294 |
2.21 (3.19) |
218 |
Who was the vaccine for? (choice=My sons and/or daughters) |
75 (5.72%) |
1312 |
75 (5.80%) |
1294 |
75 (34.4%) |
218 |
Who was the vaccine for? (choice=My mum or dad) |
8 (0.61%) |
1312 |
8 (0.62%) |
1294 |
8 (3.67%) |
218 |
Who was the vaccine for? (choice=Me) |
160 (12.2%) |
1312 |
160 (12.4%) |
1294 |
160 (73.4%) |
218 |
Who was the vaccine for? (choice=Others (open)) |
8 (0.61%) |
1312 |
8 (0.62%) |
1294 |
8 (3.67%) |
218 |
Has the fact that vaccines contain components like thiomersal, aluminium, mercury or formaldehyde caused you any doubts about vaccines? |
362 (28.1%) |
1287 |
359 (28.0%) |
1284 |
99 (45.4%) |
218 |
Has the fact that vaccines have been linked to diseases such as cancer, allergies, autism, sudden infant death syndrome, multiple sclerosis, asthma, and alterations of the immune system caused you any doubts about vaccines? |
399 (30.9%) |
1290 |
398 (30.9%) |
1288 |
101 (46.3%) |
218 |
Has the fact that you have to pay for any of the vaccines caused you any doubts about vaccination? |
374 (29.0%) |
1288 |
373 (29.0%) |
1286 |
68 (31.8%) |
214 |
Do you agree with vaccines: |
|
1291 |
|
1288 |
|
214 |
Totally agree |
982 (76.1%) |
|
982 (76.2%) |
|
112 (52.3%) |
|
|
Slightly agree |
216 (16.7%) |
|
215 (16.7%) |
|
60 (28.0%) |
|
|
Indifferent |
32 (2.48%) |
|
32 (2.48%) |
|
13 (6.07%) |
|
|
Slightly disagree |
44 (3.41%) |
|
43 (3.34%) |
|
18 (8.41%) |
|
|
Totally disagree |
17 (1.32%) |
|
16 (1.24%) |
|
11 (5.14%) |
|
|
Sum of percentages might be slightly different from 100 because of roundings.
3.2. Socio-Demographic and Sociocultural Characteristics, Beliefs, and Opinions of the Population Who Refused Vaccines
We observed a significant positive association between vaccination refusal, being 60 years old or older, and with anti-vaccination culture and family (
Table S1). There was also an association between refusing vaccination and hesitancy due to the vaccine components or associated diseases, a lack of understanding of the community-wide protection benefits of individual vaccination, and a reluctance to support compulsory vaccination even if it was free. Respondents who had refused vaccination were less inclined to view HCPs and healthcare websites as reliable sources of vaccine information than those who had not refused vaccination, and they trusted more friends. Moreover, respondents who had refused vaccination felt that HCPs lacked the information to address anti-vaccine hesitancy and would not consult HCPs, if they had a vaccine question. Finally, vaccination refusal, apart from being strongly related to total disagreement with vaccines, was also strongly related to opposition to the use of infant formula, or consumption of cow’s milk, and support of alternative medicine. (
Table S2).
In our multivariate logistic regression analysis, we found a statistically significant independent association between refusal of vaccination with the following variables: being 60 years and older; having hesitancy due to vaccine components; being against mandatory and free vaccination; not knowing that vaccination protects the community; and being against consuming cow’s milk and the use of infant formulas for breastfeeding (
Table 2).
3.3. Socio-Demographic and Sociocultural Characteristics, Beliefs and Opinions of the Population with Hesitancy Due to Vaccine Components, Associated Diseases, or Payment
Women, parents with children under 15 years old and individuals with a culture or family against vaccination were more likely to express hesitancy due to vaccine components. Also, a heightened frequency of hesitancy due to the diseases associated with vaccines was seen among certain groups. In particular, individuals under 30 years old, women, those without a university education, those with children under 15 years old, and those aligned with a culture or family against vaccination (
Table S1).
Individuals expressing hesitancy due to vaccine components (
Table S3) or associated diseases (
Table S4) were more hesitant about the payment for vaccines, were more likely unaware that individual vaccination protects the community and less likely to be in favour of free and compulsory vaccination. As for their information sources, they were more likely to report that social networks, family, and friends were reliable sources of information about vaccines. Conversely, they expressed more distrust in HCPs, and believed that HCPs are not a reliable source of information to satisfy anti-vaccine sentiments and would not consult an HCP if they had a question. There was greater hesitancy due to vaccine components or associated diseases among respondents who disagreed with vaccines, infant formula milks, cow’s milk consumption or who had diets other than the Mediterranean diet and favoured alternative and complementary treatments (
Table S3 and S4).
In our multivariate logistic regression analysis, we found a statistically significant independent association between hesitancy due to vaccine components or associated diseases with individuals under 30 years old, women, those with children under 15 years old, individuals against free and compulsory vaccination, those unaware of the community protection aspect of vaccination, individuals with hesitancy about vaccine payment or with anti-vaccine attitudes, and in favour of alternative and complementary treatments (
Table 3).
There was more hesitancy due to the payment of vaccines among people younger than 30 years old, people without a university degree, and parents with children younger than 15 years old (
Table S1). Those who were not in favour of free and compulsory vaccination, who were more likely to consider friends as reliable sources of information on vaccines, were also more likely to have hesitancy due to the payment of vaccines. People with hesitancy about vaccine payment reported that HCPs did not have enough information to satisfy people with anti-vaccine concerns. They also reported that they disagreed more with vaccines, the use of infant formula, and the consumption of cow’s milk, and more of them were in favour of alternative treatments (
Table S5)
3.4. Vaccination Behaviours by Vaccine Type and Sex
The socio-demographic features associated with various vaccines types mirrored the overall profile of vaccine refusal, albeit with some nuanced distinctions. Notably, individuals aged 60 years or older exhibited a higher refusal of influenza and tetanus vaccines. Men displayed a greater tendency to refuse tetanus vaccines, while university students showed a higher refusal to rotavirus vaccines but a lower refusal to tetanus vaccines. Parents with children under 15 years old display a higher refusal of vaccines for Haemophilus influenzae type B, Meningococcal B, and Rotavirus (
Table S6).
Men showed a higher refusal rate for tetanus vaccination, whereas women demonstrated a greater inclination to refuse vaccines for their children (
Table S7). Additionally, women, particularly those without children under 15 years old showed more hesitancy due to vaccine components or associated diseases (
Table S8).
Regarding vaccine information sources, there were no discernible sex differences in the perceived reliability of HCPs, family or friends. However, women tended to view health websites as more reliable, while men leaned towards social networks, television and radio. Moreover, a larger proportion of men strongly disagreed with vaccines, in comparison with women. Finally, women showed a stronger preference for complementary treatments, although no sex differences were seen regarding alternative treatments (
Table S7).
4. Discussion
In our study, we found that respondents generally favoured vaccination, with a refusal prevalence of 16.8%. This rate aligns with published data on the intention to refuse the COVID vaccine in the Catalan population in the same year of the study [
16].
The SAGE Vaccine Hesitancy Working Group categorize vaccine hesitancy using a matrix of contextual influences, individual/social influences, and vaccine and vaccination specific issues [
4,
17].
Our study delved into several contextual influences, particularly focusing on the sociodemographic and sociocultural characteristics of the population. Analysis of respondent age revealed higher rates of vaccine refusal among those over 60 years old. This does not coincide with previous findings from other studies, where a greater likelihood of vaccination was detected in older people because of increased health concerns and susceptibility to illness [
11,
18,
19,
20,
21]. We believe that the reason for this finding may stem from the significant rejection in our older population of the influenza vaccination, which is primarily targeted at people over 65 years old or with underlying pathologies in Spain, and from the difficulties already described in previous publications to achieve satisfactory vaccination coverage against influenza [
21,
22,
23,
24]. We also detected greater hesitancy due to the diseases associated with vaccines or to the payment for vaccines in people under 30 years old, and this matches previously published studies [
11,
18,
19,
20,
21].
When considering sex, our study revealed that women and parents with children under 15 years old, showed greater hesitancy due to the components of vaccines or diseases that have been associated with vaccines. Greater doubts were detected in women without children under 15 years old than in men. Moreover, women were more likely to refuse vaccines for their children, aligning with previous studies, which show a greater predisposition to vaccination in men than in women, and less acceptance and greater hesitancy in parents [
11,
18,
25,
26]. Concretely, women with young children are more concerned about vaccinating their children, necessitating targeted strategies to bolster the trust and confidence, as previously proposed [
11,
18,
26,
27].
Regarding education level, individuals without a university education exhibited greater hesitancy due to associated diseases or vaccine payment. This aligns with published studies that show that the higher the level of education, the greater the acceptance of vaccines [
11,
18,
20,
23,
28].
Cultural, religious, and family beliefs emerged as influential factors associated with hesitancy and decision about vaccination, with a greater predisposition to get vaccinated if the sociocultural environment is provaccine. These results echo findings from prior studies [
3,
10,
18].
In terms of political and policy-related contextual influences, most respondents favoured free and compulsory vaccination, except those who refused vaccines or expressed hesitation because of components, associated diseases, or payment for vaccines. Although in recent years there has been growing traction for anti-vaccine movements, most of the population seems to be in favour of compulsory vaccination policies, as evidenced in a 2019 review. Moreover, it seems that support towards mandatory policies increases after their implementation [
29]. Nonetheless, efforts to improve vaccine acceptance, such as enhancing education and providing proof of the efficacy, benefits and safety of vaccines, remain crucial [
30].
We observed greater vaccine refusal and hesitancy among individuals who deemed health professionals or websites unreliable sources of vaccine information, while considering friends, family, or social networks as reliable sources. These results reinforce previous publications which stated that the crisis in the vaccination system and the resurgence of anti-vaccine movements are due to the increased accessibility of information and the reduced credibility of HCPs [
5,
31]. Exposure to anti-vaccine content on social media was associated with refusal and hesitancy to vaccinate [
32,
33,
34,
35,
36], highlighting the critical need to combat misinformation to mitigate its effects [
34,
35].
Our study also suggests that a lack of trust in HCPs is associated with greater vaccine refusal and hesitancy. This aligns with existing reviews and published studies that conclude that vaccine safety and trust in health authorities are the main factors in promoting vaccine acceptance [
11,
37]. According to the WHO’s “3Cs” model (confidence, compliance, convenience), confidence in vaccines and in the healthcare system constitute one of the three main determinants of vaccine hesitancy [
4,
7,
17].
We detected a greater refusal of the vaccines for influenza, tetanus, papilloma, and varicella (chicken pox). Mostly individuals refused vaccines for themselves and, to a lesser extent, their children. These findings mirror other international studies which highlight the difficulties in achieving satisfactory vaccination coverage for influenza and papillomavirus [
30,
35,
38]. Data published by the Spanish Ministry of Health also corroborate these difficulties in vaccination coverage for influenza, papilloma, and varicella in 2021-2022. In Spain, the recommendation to maintain vaccination coverage ≥95% for MMR vaccination in 2021-2022 was not achieved [
12] and the goal of maintaining measles and rubella elimination status was not met [
39]. Again, although there are high coverage rates for tetanus in primary vaccination with the hexavalent vaccine, vaccination coverage with Td decreases in adolescents [
12]. In our study, we found a greater refusal of tetanus vaccine than the diphtheria vaccine, although tetanus and diphtheria vaccines are usually administered together. We attribute this difference and other similar ones to a possible lack of knowledge of the vaccination schedule in our reference population or to a greater popular knowledge of tetanus vaccine because of its indication for administration in certain wounds.
Our study revealed a relationship between having hesitancy due to vaccine components and refusing a vaccine. It also showed that having hesitancy due to vaccine components or associated diseases were associated with hesitancy due to vaccine payment. Earlier research has found that accessibility and cost, along with safety and efficacy were reasons for hesitancy [
11,
17,
40]. In most Spanish autonomous communities, the Meningococcal ACWY and Meningococcal B vaccines are now part of the public vaccination schedule and thus should no longer be a reason for hesitancy because of costs in these cases [
41].
Collective responsibility was assessed and greater refusal and hesitancy was detected in respondents who were unaware that individual vaccination protects the community. The concept of collective responsibility was one of five factors that affect people’s perception of vaccines, along with confidence (trust in vaccine efficacy and safety), complacency (perception about the risk of the disease), calculation (weighing the risks and benefits of vaccines) and constraint (accessibility of information about the vaccine). These are part of the 5Cs model [
38], which extends from the 3C model introduced by the WHO SAGE Working group [
4].
We intended to study the profile of the local population with vaccine hesitancy and we observed heightened hesitancy among people who disagreed with cow’s milk consumption or the use of infant milk formulas, and those who adhered to a non-Mediterranean diet or favoured alternative or complementary treatments for healthcare. This profile of population with a preference for natural therapies, with scepticism towards established scientific positions, and greater reticence towards healthcare systems and HCPs, seems to be the profile of vaccine hesitancy detected in primary care. To address vaccine hesitancy, we urge institutions and governmental bodies to seek strategies to enhance trust in HCPs, public health systems, authorities, and health policies. Encouraging shared participation in the formulation of vaccine recommendations is paramount [
37]. Additionally, as previously suggested by some authors, novel approaches such as analysing population opinions on vaccination through social networks using artificial intelligence to complement traditional survey methods, can provide a more comprehensive understanding of vaccine refusal and hesitancy dynamics and allow targeted interventions. Such initiatives can facilitate effective engagement with diverse communities and foster informed decision-making regarding vaccination [
33,
42,
43,
44,
45].
One of the limitations of this study is the inherent recruitment bias associated with the online survey method, which restricted participation to individuals with internet access. However, given that 96.1% of Spanish households have internet access, and 85% of Spaniards are users of social networks [
46,
47], the reach of our survey remains substantial. While most respondents were Catalan, we believe that vaccination behaviour is fairly homogenous across Spain. Another possible limitation is potential respondent repetition, although, we anticipate minimal impact on the final results because of expected low rate of repetition. Additionally, our sample skewed towards women and people with a university education, this could limit the interpretation and generalization of our study to the broader population. Finally, reaching the anti-vaccine population posed challenges, as interactions with these groups is difficult. To mitigate eventual bias deriving from this, in our sample size calculation, we considered that the proportion of antivaccine responses would be much lower than the proportion of pro-vaccine responses. Despite these limitations, our study provides valuable insights into vaccine refusal and hesitancy, but caution is warranted in extrapolating findings to the entire population.
5. Conclusions
Vaccination refusal in our surveyed population was low and mainly related to refusal of influenza vaccination, although hesitancy arguments related to vaccine safety were detected, which could compromise vaccination coverage.
Vaccine refusal was mainly associated with individuals over 60 years old, characterized by hesitancy towards vaccine components, a resistance to compulsory vaccination, and a lack of awareness regarding vaccination’s community-wide protection benefits. Furthermore, resistance extended to dietary choices, notably being against cow’s milk and the use of infant formulas for breastfeeding.
Vaccine hesitancy, on the other hand, was mainly associated with a younger demographic of people under 30 years old, typically women, parents of young children under 15 years old, and against compulsory vaccination. They were generally also unaware that vaccination protects the community, with hesitancy about vaccine payment or with anti-vaccine attitudes, and in favour of alternative and complementary treatments.
In general, greater hesitancy to vaccination was detected in women and they reported a greater refusal to vaccinate their children than men.
Addressing these complexities requires proactive health policies aimed at strengthening trust in scientific positions and HCPs. Additionally, strategies must be tailored to enhance community engagement and ensure sufficient education regarding vaccination, especially among populations with lingering doubts. Multifaceted approaches are indispensable for navigating the intricacies of vaccine acceptance and safeguarding public health in the face of evolving challenges and threats to established progress made at reducing vaccine refusal and hesitancy.
Supplementary Materials
The following supporting information can be downloaded at the website of this paper posted on Preprints.org., Table S1: Socialdemographic and sociocultural characteristics of the populations refusing or showing hesitancy about vaccination; Table S2: Characteristics of the population of the populations refusing vaccination; Table S3: Characteristics of the population with hesitancy due to vaccine components; Table S4: Characteristics of the population with hesitancy due to diseases attributed to vaccines, Table S5: Charactersitics of the population with hesitancy due to the payment of vaccines; Table S6: Refusal by type of vaccine, Table S7: Vaccination behaviours by sex; Table S8. Results by sex and children.
Author Contributions
AH-F, EA-B, MOB contributed to the study concept and research design, selected, and reviewed the literature on vaccination. JS and XG-A participated in the acquisition, analysis, and interpretation of data. AH-F, EA-B, MOB, JS, XG-A and PG participated in the writing and critical review of the manuscript and approved the final version. AH-F and Group MC-MUVA contributed to the recruitment.
Funding
This work was supported by Ajuts a Projectes en Projectes en Recerca en Atenció Primària-Diputació Lleida 2021-1a Edició (Ajut PICARD) modalitat projecte (4R22/152) y modalitat publicació i traducció d’articles (9F22/017) and by BECA AEPap-FPS 2020 for research in Primary Care Paediatrics.
Institutional Review Board Statement
This study was approved by the Ethics and Clinical Research Committee of the Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), with code 20/221-P. The study was conducted following the principles of the Declaration of Helsinki.
Informed Consent Statement
Informed consent was obtained from all the subjects involved in the study.
Data Availability Statement
The data are hosted on the research team’s internal servers and will be provided under reasonable request.
Acknowledgments
Data collection would not have been possible without the collaboration of the MC- MUVA work group, the Xarxa de Recerca en Pediatria d’Atenció Primària [Research Network of Primary Care Paediatrics], and the Societat Catalana de Pediatria [Catalan Society of Paediatrics]. Our special thanks go to the dedicated investigators and participants. MC-MUVA work group: Rebecca Oglesby, Merce Font Arbó, Lidia Sanz Borrell, Mireia Biosca Pàmies, Marta Pifarre Ortiz, Sara Martí Martí, Daniel Gros Esteban, Laura Guix Cliville, Noelia Diaz Charles, Silvia Prado Muñoz, Susana Perez Osuna, Mercè Giribet Folch, Magda Riera Veciana, Carles Gatius Tonda, Laura Seoane Barbosa, Pilar Serra Solans, Míriam Poblet, M. José Castañ Castillo, Elena Alcover Bloch, Anna Castan, Magda Barberà Farré, Sara Serra Font, Mònica Martinez, Imma Caubet Busquet, Maria Planella Cornudella, Gema Terrer Manrique, Raul Morales, Anna Gatell Carbo, Carme Farran Balcells,Carmen Gómez Seara, Viktoriya Atroshchenko Shushko, Margaret Creus Verni, Veronida Mª Karcz, Judith Palacin Aguilà, Joana Garcia Hinojosa, Mihaela Cozar, Rosa Aran Padullés, Ramón Capdevila Bert,Montse Crespo Pons, Maria Jose Lara Tostado, Isabel Segarra Solanes, Enmanuel Aneudi Estevez Genao, Raquel Plasencia Atienza, Maria Chiné Segura, Meritxell Pelegrí Romeo, Montse Farran Jové, Carme Trilla Felis, Rubén Lopez Ruiz, Iratxe Olabegoya Estrela, Roser Racero Maire, Sonia Asensio, Merce Lozano Vergara, Mercè Cortés Lladó, Àngels Font Anglada, Sara Borrat Padrosa, Maria Payan Sala, Bárbara Montilla Cabrera, Samanta Barisonzi Zambrano, Almudena Sanchez, Cristina Casademont, Pyrene Martinez, Anna M. Ristol Perxés, Irene Gómez i Pérez, Jaume Miquel Salsas..
Conflicts of Interest
The authors declare that they have no competing interests.
References
- OMS. Vacunas e inmunización: la seguridad de las vacunas. 2020 [accessed 2023-11-26]. Available from: https://www.who.int/es/news-room/questions-and-answers/item/vaccines-and-immunization-vaccine-safety.
- Chen, C.; Yang, Q.; Tian, H.; Wu, J.; Chen, L.; Ji, Z.; Zheng, D.; Chen, Y.; Li, Z.; Lu, H. Bibliometric and visual analysis of vaccination hesitancy research from 2013 to 2022. Hum. Vaccines Immunother. 2023, 19, 2226584. [CrossRef]
- Swingle CA. How Do We Approach Anti-Vaccination Attitudes? Mo Med. 2018;115(3):180-1.
- Meeting of the Strategic Advisory Group of Experts on immunization, October 2017 – conclusions and recommendations. Wkly Epidemiol Rec. 2017;92(48):729-47.
- Hussain, A.; Ali, S.; Ahmed, M.; Hussain, S. The Anti-vaccination Movement: A Regression in Modern Medicine. Cureus 2018, 10, e2919. [CrossRef]
- Tafuri, S.; Gallone, M.S.; Cappelli, M.G.; Martinelli, D.; Prato, R.; Germinario, C. Addressing the anti-vaccination movement and the role of HCWs. Vaccine 2014, 32, 4860–4865. [CrossRef]
- MacDonald, N.E.; Eskola, J.; Liang, X.; Chaudhuri, M.; Dube, E.; Gellin, B.; Goldstein, S.; Larson, H.; Manzo, M.L.; Reingold, A.; et al. Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine 2015, 33, 4161–4164.
- OMS. Diez cuestiones de salud que la OMS abordará este año. 2019 [Accessed 20 May 2020]. Available from: https://www.who.int/es/news-room/spotlight/ten-threats-to-global-health-in-2019.
- Ozawa, S.; Yemeke, T.T.; Evans, D.R.; Pallas, S.E.; Wallace, A.S.; Lee, B.Y. Defining hard-to-reach populations for vaccination. Vaccine 2019, 37, 5525–5534. [CrossRef]
- Hornsey, M.J.; Harris, E.A.; Fielding, K.S. The psychological roots of anti-vaccination attitudes: A 24-nation investigation.. Heal. Psychol. 2018, 37, 307–315. [CrossRef]
- Truong, J.; Bakshi, S.; Wasim, A.; Ahmad, M.; Majid, U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Heal. Promot. Int. 2021, 37. [CrossRef]
- Vacunas y Programa de Vacunación. Coberturas de Vacunación. Datos Estadísticos. Ministerio de Sanidad. Gobierno de España.2023 [accessed 2024-01-07]. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/calendario-y-coberturas/coberturas/home.htm.
- Picchio, C.A.; Carrasco, M.G.; Sagué-Vilavella, M.; Rius, C. Knowledge, attitudes and beliefs about vaccination in primary healthcare workers involved in the administration of systematic childhood vaccines, Barcelona, 2016/17. Eurosurveillance 2019, 24, 1800117. [CrossRef]
- Caballero P, Astray J, Domínguez Á, Godoy P, Barrabeig I, Castilla J, et al. [Validation of the questionnaire on vaccines and hesitancy to be vaccinated in the Spanish Society of Epidemiology]. Gac Sanit. 2023;37:102329.
- IDIAP JordiGol. REDCap. [accessed 2023-02-06]. Available from: https://redcap.link/uj4jozhy.
- Huguet-Feixa, A.; Artigues-Barberà, E.; Sol, J.; Godoy, P.; Bravo, M.O.; Muva, M. Effects of the COVID-19 Pandemic on the Decision and Doubts About Vaccination in Catalonia: Online Cross-sectional Questionnaire. JMIR Form. Res. 2023, 7, e41799. [CrossRef]
- Larson, H.J.; Jarrett, C.; Schulz, W.S.; Chaudhuri, M.; Zhou, Y.; Dubé, E.; Schuster, M.; MacDonald, N.E.; Wilson, R.; The SAGE Working Group on Vaccine Hesitancy. Measuring vaccine hesitancy: The development of a survey tool. Vaccine 2015, 33, 4165–4175. [CrossRef]
- Joshi, A.; Kaur, M.; Kaur, R.; Grover, A.; Nash, D.; El-Mohandes, A. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front. Public Heal. 2021, 9, 698111. [CrossRef]
- Gagneux-Brunon, A.; Detoc, M.; Bruel, S.; Tardy, B.; Rozaire, O.; Frappe, P.; Botelho-Nevers, E. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: A cross-sectional survey. J. Hosp. Infect. 2021, 108, 168–173. [CrossRef]
- Troiano, G.; Nardi, A. Vaccine hesitancy in the era of COVID-19. Public Health 2021, 194, 245–251. [CrossRef]
- Rönnerstrand, B. Social capital and immunisation against the 2009 A(H1N1) pandemic in Sweden. Scand. J. Public Heal. 2013, 41, 853–859. [CrossRef]
- Mesch, G.S.; Schwirian, K.P. Social and political determinants of vaccine hesitancy: Lessons learned from the H1N1 pandemic of 2009-2010. Am. J. Infect. Control. 2015, 43, 1161–1165. [CrossRef]
- Börjesson, M.; Enander, A. Perceptions and sociodemographic factors influencing vaccination uptake and precautionary behaviours in response to the A/H1N1 influenza in Sweden. Scand. J. Public Heal. 2013, 42, 215–222. [CrossRef]
- Ferrante G, Baldissera S, Moghadam PF, Carrozzi G, Trinito MO, Salmaso S. Surveillance of perceptions, knowledge, attitudes and behaviors of the Italian adult population (18-69 years) during the 2009-2010 A/H1N1 influenza pandemic. Eur J Epidemiol. 2011;26(3):211-9.
- Damnjanović, K.; Graeber, J.; Ilić, S.; Lam, W.Y.; Lep, .; Morales, S.; Pulkkinen, T.; Vingerhoets, L. Parental Decision-Making on Childhood Vaccination. Front. Psychol. 2018, 9, 735. [CrossRef]
- Benin, A.L.; Wisler-Scher, D.J.; Colson, E.; Shapiro, E.D.; Holmboe, E.S. Qualitative Analysis of Mothers' Decision-Making About Vaccines for Infants: The Importance of Trust. PEDIATRICS 2006, 117, 1532–1541. [CrossRef]
- Hilton, S.; Smith, E. Public views of the uk media and government reaction to the 2009 swine flu pandemic. BMC Public Heal. 2010, 10, 697–697. [CrossRef]
- Myers, L.B.; Goodwin, R. Determinants of adults' intention to vaccinate against pandemic swine flu. BMC Public Heal. 2011, 11, 15–15. [CrossRef]
- Seale, H.; Leask, J.; MacIntyre, C.R. Awareness, attitudes and behavior of hospital healthcare workers towards a mandatory vaccination directive: Two years on. Vaccine 2011, 29, 3734–3737. [CrossRef]
- Gualano, M.R.; Olivero, E.; Voglino, G.; Corezzi, M.; Rossello, P.; Vicentini, C.; Bert, F.; Siliquini, R. Knowledge, attitudes and beliefs towards compulsory vaccination: a systematic review. Hum. Vaccines Immunother. 2019, 15, 918–931. [CrossRef]
- Larson, H.J.; Schulz, W.S. Reverse global vaccine dissent. Science 2019, 364, 105–105. [CrossRef]
- Margolis, M.A.; Brewer, N.T.; Shah, P.D.; Calo, W.A.; Gilkey, M.B. Stories about HPV vaccine in social media, traditional media, and conversations. Prev. Med. 2019, 118, 251–256. [CrossRef]
- Argyris, Y.A.; Monu, K.; Tan, P.-N.; Aarts, C.; Jiang, F.; Wiseley, K.A. Using Machine Learning to Compare Provaccine and Antivaccine Discourse Among the Public on Social Media: Algorithm Development Study. JMIR Public Heal. Surveill. 2021, 7, e23105. [CrossRef]
- Badur, S.; Ota, M.; Ozturk, S.; Adegbola, R.; Dutta, A. Vaccine confidence: the keys to restoring trust. Hum. Vaccines Immunother. 2020, 16, 1007–1017. [CrossRef]
- Dunn, A.G.; Surian, D.; Leask, J.; Dey, A.; Mandl, K.D.; Coiera, E. Mapping information exposure on social media to explain differences in HPV vaccine coverage in the United States. Vaccine 2017, 35, 3033–3040. [CrossRef]
- Burki T. The online anti-vaccine movement in the age of COVID-19. Lancet Digit Health. 2020;2(10):e504-e5.
- Paterson, P.; Meurice, F.; Stanberry, L.R.; Glismann, S.; Rosenthal, S.L.; Larson, H.J. Vaccine hesitancy and healthcare providers. Vaccine 2016, 34, 6700–6706. [CrossRef]
- Ahmed, N.; Quinn, S.C.; Hancock, G.R.; Freimuth, V.S.; Jamison, A. Social media use and influenza vaccine uptake among White and African American adults. Vaccine 2018, 36, 7556–7561. [CrossRef]
- Plan estratégico para la eliminación del sarampión y la rubeola en España 2021-2025: Ministerio de Sanidad. Gobierno de España; 2021 [accessed 2024-01-19]. Available from: www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/sarampion-rubeola/docs/PlanEstrategico_SarampionyRubeola.pdf.
- Betsch, C.; Schmid, P.; Heinemeier, D.; Korn, L.; Holtmann, C.; Böhm, R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLOS ONE 2018, 13, e0208601. [CrossRef]
- Vacunas y Programa de Vacunación. Calendarios de vacunación en las Comunidades Autónomas.: Ministerio de Sanidad. Gobierno de España.; 2023 [accessed 2023-01-07]. Available from: ttps://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario-y-coberturas/calendario/Calendario_CCAA.htm.
- Hussain, A.; Tahir, A.; Hussain, Z.; Sheikh, Z.; Gogate, M.; Dashtipour, K.; Ali, A.; Sheikh, A. Artificial Intelligence–Enabled Analysis of Public Attitudes on Facebook and Twitter Toward COVID-19 Vaccines in the United Kingdom and the United States: Observational Study. J. Med Internet Res. 2021, 23, e26627. [CrossRef]
- Kwok, S.W.H.; Vadde, S.K.; Wang, G. Tweet Topics and Sentiments Relating to COVID-19 Vaccination Among Australian Twitter Users: Machine Learning Analysis. J. Med Internet Res. 2021, 23, e26953. [CrossRef]
- To, Q.G.; To, K.G.; Huynh, V.-A.N.; Nguyen, N.T.; Ngo, D.T.; Alley, S.; Tran, A.N.; Pham, N.T.; Bui, T.X.; Vandelanotte, C. Anti-vaccination attitude trends during the COVID-19 pandemic: A machine learning-based analysis of tweets. Digit. Heal. 2023, 9. [CrossRef]
- Ahmed, W.; Vidal-Alaball, J.; Vilaseca, J.M. A Social Network Analysis of Twitter Data Related to Blood Clots and Vaccines. Int. J. Environ. Res. Public Heal. 2022, 19, 4584. [CrossRef]
- Idescat. Llars amb accés a Internet: Institut d’Estadística de Catalunya; 2022 [Accessed 28 Nov 2023]. Available from: https://www.idescat.cat/indicadors/?id=ue&n=10144.
- Statista. Penetración de las redes sociales en España de 2010 a 2023 2023 [Accessed 28 Nov 2023]. Available from: https://es.statista.com/estadisticas/910163/redes-sociales-porcentaje-de-usuarios-por-comunidad-autonoma-en-espana/.
Table 2.
Dependent variable: Refusal of vaccination.
Table 2.
Dependent variable: Refusal of vaccination.
Significant Independent Variable |
p-Value |
OR |
95% CI OR inf |
95% CI OR sup |
Age group |
|
|
|
|
30 years old or less |
0.004 |
0.403 |
0.219 |
0.742 |
31-59 years old |
0,001 |
0.491 |
|
|
60 years old or more |
Ref |
Ref |
|
|
Knowledge of protecting more people |
0.005 |
0.390 |
0.202 |
0.754 |
Desire for free and compulsory vaccination |
0.000 |
0.278 |
0.200 |
0.386 |
Hesitancy due to vaccine components |
0.003 |
1.676 |
1.195 |
2.352 |
Opinion on use of infant formula |
0.069 |
0.684 |
0.454 |
1.030 |
Opinion on consumption of cow’s milk |
0.021 |
0.607 |
0.397 |
0.929 |
Constant |
0.005 |
3.521 |
|
|
Table 3.
Dependent variable: Hesitancy due to vaccine components or associated diseases.
Table 3.
Dependent variable: Hesitancy due to vaccine components or associated diseases.
Significant Independent Variables |
p-Value |
OR |
95%CI OR Inf |
95% CI OR Sup |
Age group |
|
|
|
|
30 years old or less |
0.190 |
1,384 |
0.851 |
2.253 |
31-59 years old |
0.093 |
0.695 |
0.454 |
1.062 |
60 years old or more |
Ref |
Ref |
|
|
Sex |
0.009 |
1.494 |
1.104 |
2.023 |
Children under 15 years old |
0.006 |
0.669 |
0.502 |
0.891 |
Knowledge of protecting more people |
0.019 |
0.418 |
0.202 |
0.864 |
Desire for free and compulsory vaccination |
0.000 |
0.436 |
0.331 |
0.573 |
Hesitancy due to payment for a vaccine |
0.000 |
0.459 |
0.351 |
0.600 |
Opinion on vaccination |
0.002 |
0.307 |
0.148 |
0.637 |
Use of alternative treatments |
0.000 |
0.488 |
0.350 |
0.680 |
Use of complementary treatments |
0.001 |
1.549 |
1.183 |
2.029 |
Constant |
0.000 |
41.261 |
|
|
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).